Early bird discount for Vaccine Antigen Delivery: new approaches to vaccine development




  • The Deadline for abstract submissions for oral presentation is 10th July 2016
  • The early registration deadline is 20th August 2016
  • The Poster submission deadline is 11th October 2016

 This international event will discuss new cellular, molecular and chemical approaches to improving immunisation efficacy.

Who Should Attend: This event is aimed at those working in all aspects of vaccine research and development, including but not limited to those involved in academic and pharmaceutical R&D, and clinicians with an interest in vaccination.

We encourage questions, discussion and debate from all attendees and aim for a relaxed atmosphere to generate maximum interaction online

After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.

The event will be recorded and available for all registered delegates up to a month after the event.  So if you can’t manage all the days, or the different time zones, you can still have access to the full event.

Invited speakers and talk titles include

Talk TitleSpeakerAffiliationCountry
Vaccine adjuvants; the good, the bad and the uglyProfessor Nikolai PetrovskyFlinders UniversityAustralia
Lentiviral pseudotypes as a tool for vaccine efficacy testingGeorge CarnellUniversities of Greenwich and KentUnited Kingdom
ARV-derived IC-Tagging methodology for production of epitope-loaded protein microspheres for adjuvant-free vaccinationDr. Jose Martinez CostasUniversidad de Santiago de CompostelaSpain
Design of Microneedles Formulations for Vaccine DeliveryDr. Abina CreanUniversity College CorkIreland
Towards development of more effective vaccines: new generation of potent adjuvants with antigen delivery ability.Dr. Ilona KubajewskaUCL School of Pharmacy, LondonUnited Kingdom
Influenza antigen delivery using protein transfer modied VLPsDr. Periasamy SelvarajEmory University School of MedicineUnited States
Talk title to be confirmedLakshmi KrishnanNational Research Council of Canada-Human Health TherapeuticsCanada
Genetics epigenetics and vaccine protective efficacyDr. Huanmin ZhangUSDA, Agriculture Research ServiceUnited States
Micro-fractional delivery of powdered vaccines into the skinAssociate Professor Mei X. Wu, WellmanMassachusetts General Hospital, Harvard Medical SchoolUnited States
Ebola vaccines: past, present and futureDr Edward WrightUniversity of WestminsterUnited Kingdom
Engineered nanomedicine for cancer immunotherapyDr. James J. MoonUniversity of Michigan, Ann ArborUnited States
Exploiting materials chemistry for tuneable vaccine formulationsDr. Gareth R WilliamsUCL School of PharmacyUnited Kingdom
The March Toward Licensure and Deployment of a PfSPZ Malaria VaccineDr. Stephen L. HoffmanSanaria Inc., RockvilleUnited States
Multi-tasking influenza vaccines to provide rapide innate and subsequent long-term adpative immunity against influenza and secondary pneumococcal infections Dr. Brendon Yew Loong ChuaThe University of MelbourneAustralia
Talk title to be confirmedProfessor Nirbhay Kumar, PhD, FASTMH, William G. Vincent Endowed ProfessorTulane UniversityUnited States

Register now for this Euroscicon Event

Registration Fees

Advisory Board Members

Dr Gary R McLeanImperial College LondonUnited Kingdom
Dr Jonathan LewisMolecular Ninja TherapeuticsUnited States
Dr Simon ScottUniversity of KentUnited Kingdom
Dr Beata GromadzkaUniversity of GdanskPoland
Dr Kathleen L. HefferonUniversity of TorontoCanada

Vaccine Antigen Delivery has an open abstract session: 

Abstracts can be submitted on any subject related to Vaccines and Vaccination

Abstract Submission

Poster Submission

CPD Credits



Payment Instructions

Payment must be received prior to the meeting

Credit card
You can pay during your online registration using your credit card. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered

You can either use your Paypal account or click on the no account link to pay directly by credit or debit card

The information taken will be by secure server.

We do not store credit card details nor do we share customer details with any 3rd parties

If you wish to pay by?cheque, purchase order?or?bank transfer, please contact bilal.ahmad [@]

Why attend a Live Streamed Event

As Euroscicon are the first to run virtual Life Science conferences we thought you might be unfamiliar with the benefits of attending.  

Please view these meetings as you would a usual conference,  but with the following advantages

  • Less travel time means more time for you at work and at home`
  • Access the whole event from the com­fort of your own home or office
  • Reg­is­tra­tion Fees are much less than a “bricks and mor­tar” event
  • No expen­di­ture on hotels and sundries
  • Con­nect with a larger and more global audi­ence, many of whom may have not attended due to cost and travel constraints
  • Catch up on missed talks in the evening or your free time
  • No flight delays, pass­port con­trol or secu­rity checks
  • Jug­gle work demands with con­fer­ence attendance
  • Dip in and out of talks with­out being noticed
  • No pack­ing and unpack­ing and won­der­ing whether your lug­gage will make it through to the other side
  • Access all con­fer­ence mate­ri­als and audio online for 1 month after the event
  • Eas­ily locate con­fer­ence atten­dees and arrange a con­fer­ence call, rather than search­ing hotel lob­bies for your clients
  • Save hun­dreds of thou­sands of gal­lons of air fuel because of the aggre­gate efforts of attendees

FAQ about our Live Streamed Events

To find out more about out internet conferences please click here

Delegate lists

Delegate lists are only available to participants who have registered for an event and with a zero balance.

Click here for instructions on downloading the delegate list

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: